First-Line Sunitinib Leads to Radiological Stability in Patients With RCC in VHL Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
First-Line Sunitinib in Patients With Renal Cell Carcinoma (RCC) in von Hippel-Lindau (VHL) Disease: Clinical Outcome and Patterns of Radiological Response
Fam. Cancer 2015 Jun 01;14(2)309-316, A Roma, M Maruzzo, U Basso, A Brunello, R Zamarchi, E Bezzon, F Pomerri, S Zovato, G Opocher, V ZagonelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.